What is the diagnosis for a patient with scatter properties compatible with small to intermediate cell size, characterized by the following immunophenotype: CD45 (Cluster of Differentiation 45) positive, CD5 (Cluster of Differentiation 5) positive, CD10 (Cluster of Differentiation 10) negative, CD11b (Cluster of Differentiation 11b) negative, CD11c (Cluster of Differentiation 11c) negative, CD19 (Cluster of Differentiation 19) positive, CD20 (Cluster of Differentiation 20) dim, CD22 (Cluster of Differentiation 22) dim, CD23 (Cluster of Differentiation 23) positive, CD38 (Cluster of Differentiation 38) negative, FMC7 (Fluorescence Monoclonal antibody Cluster 7) negative, HLA-DR (Human Leukocyte Antigen - DR) positive, and surface immunoglobulin kappa positive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis

  • Single most likely diagnosis
    • Chronic Lymphocytic Leukemia (CLL): The presence of CD45+, CD5+, CD19+, CD20+ (dim), CD22+ (dim), and CD23+ is highly suggestive of CLL. The dim expression of CD20 and CD22, along with the presence of CD23, are characteristic of this disease.
  • Other Likely diagnoses
    • Mantle Cell Lymphoma (MCL): Although less likely than CLL, MCL can also express CD5 and CD19. However, MCL typically has brighter CD20 expression and often lacks CD23.
    • Follicular Lymphoma: This diagnosis is less likely due to the absence of CD10, but some cases of follicular lymphoma can be CD10 negative. The presence of CD5 and CD23 would be unusual for follicular lymphoma.
  • Do Not Miss
    • Richter's Transformation: This is a transformation of CLL to a more aggressive lymphoma, often diffuse large B-cell lymphoma. Although the immunophenotype provided does not strongly suggest this diagnosis, it is crucial not to miss it due to its aggressive nature and different treatment approach.
    • Prolymphocytic Leukemia: This rare leukemia can present with a similar immunophenotype to CLL but typically has brighter expression of surface immunoglobulin and often lacks CD23.
  • Rare diagnoses
    • B-cell Prolymphocytic Leukemia (B-PLL): Characterized by a high proportion of prolymphocytes in the blood, B-PLL can have a similar immunophenotype to CLL but usually lacks CD23 and has brighter sIg expression.
    • Splenic Marginal Zone Lymphoma (SMZL): This rare lymphoma can have a variable immunophenotype, but the presence of CD5 and CD23 would be unusual. SMZL often lacks CD5 and can have a distinct pattern of villous lymphocytes in the blood.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.